Skip to main content
. 2017 Oct 28;17:835–846. doi: 10.1016/j.nicl.2017.10.025

Table 1.

Demographic characteristics of XDP and Control cohorts.

XDP patients Controls *statistic(p)
17 XDP vs. 17 controls Age 40.5 ± 8.2 y 37.2 ± 7.9 y F = 1.420(0.242)
Sex (male/female) 16/1 15/2 χ2 = 0.366(0.500)
Handedness (R/L/Ambidex) 15/1/1 16/0/1 χ2 = 1.032(0.597)
Scanner (Achieva/Ingenia) 13/4 16/1 χ2 = 0.211(0.168)
Age at onset (range) 36.6 ± 7.2 y (29–49)
BFM-M total (range) 51.3 ± 23.1 (3.5–88)
BFM-M speech (range) 7.3 ± 5.5 (0–16)
UPDRS-III total (range) 37.6** ± 16.4 (5–62)
HADS-D (range, n) 5.9 ± 2.2 (3–9, 8)
HADS-A (range, n) (7.7 ± 3.5 (1–12, 7)
10 XDP vs. 10 controls Age 39.5 ± 6.5 y 38.8 ± 7.7 y F = 0.048(0.829)
Sex (male/female) 10/0 10/0
Handedness (R/L/Ambidex) 8/1/1 9/0/1 χ2 = 1.059(0.589)
Scanner
(Achieva/Ingenia)
10/0 10/0
Age at onset (range) 36.3 ± 6.6 y (29–48)
BFM-M total (range) 45.4 ± 25.3 (3.5–81)
BFM-M speech (range) 7.8 ± 6.2 (0–16)
UPDRS-III total (range) 33.9 ± 18.1 (5–62)
HADS-D (range, n) 5.8 ± 2.3 (3–9, 6)
HADS-A (range, n) 8.0 ± 4.2 (1–12, 5)

XDP: X-linked dystonia-parkinsonism.

*For categorical variables we used Chi-Square tests and for continuous variables we used ANOVAs. No statistics were performed for variables that matched 100% between groups.

**Please see Methods Section 2.2 regarding the effects of dystonia symptoms on UPDRS scores. The patients in this study scored high primarily due to severe dystonia.